Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dingyuan Hu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Clinical Laboratory|June 15, 2026
CLCA1 Modulates Pancreatic Cancer Proliferation via SIRT1-HIF-1α PathwayDingyuan Hu, Yilei Yang, Jinlin Ge, et al.
Anticancer Research|July 3, 2019
The Hippo Signaling Pathway in Pancreatic CancerDaniel Ansari, Henrik Ohlsson, Carl Althini, et al.
Molecules (Basel, Switzerland)|March 14, 2026
Trimetallic Zeolitic Imidazolate Framework-Derived CoNiO<sub>2</sub>/NiCo<sub>2</sub>O<sub>4</sub>/NiFe<sub>2</sub>O<sub>4</sub> Hierarchical Architecture: Unveiling Multi-Component Synergism for Ultrahigh-Capacity and Highly Stable Lithium StorageDingyuan Hu, Ningbo Yu, Wei Hua, et al.
Internal and Emergency Medicine|April 17, 2026
Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trialYe Fang, Luyan Fang, Dingyuan Hu, et al.
BMC Cancer|November 14, 2018
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinomaDingyuan Hu, Daniel Ansari, Qimin Zhou, et al.
International Journal of Colorectal Disease|September 7, 2024
Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021Daopo Lin, Yang Jin, Xiaoxiao Shao, et al.
Zhonghua Nei Ke Za Zhi|September 30, 2014
[Associations of the decoy receptor and osteoprotegerin gene polymorphisms with ulcerative colitis in Chinese patients]Xiangyun Zheng, Ping Jiang, Hao Wu, et al.
Journal of Translational Medicine|September 5, 2020
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic markerJohannes Byrling, Theresa Kristl, Dingyuan Hu, et al.
Frontiers in Pharmacology|July 6, 2023
Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trialsDingyuan Hu, Liming Chen, Diqin Yan, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 12, 2019
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosisQimin Zhou, Roland Andersson, Dingyuan Hu, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical Laboratory|June 15, 2026
CLCA1 Modulates Pancreatic Cancer Proliferation via SIRT1-HIF-1α PathwayDingyuan Hu, Yilei Yang, Jinlin Ge, et al.
Anticancer Research|July 3, 2019
The Hippo Signaling Pathway in Pancreatic CancerDaniel Ansari, Henrik Ohlsson, Carl Althini, et al.
Molecules (Basel, Switzerland)|March 14, 2026
Trimetallic Zeolitic Imidazolate Framework-Derived CoNiO<sub>2</sub>/NiCo<sub>2</sub>O<sub>4</sub>/NiFe<sub>2</sub>O<sub>4</sub> Hierarchical Architecture: Unveiling Multi-Component Synergism for Ultrahigh-Capacity and Highly Stable Lithium StorageDingyuan Hu, Ningbo Yu, Wei Hua, et al.
Internal and Emergency Medicine|April 17, 2026
Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trialYe Fang, Luyan Fang, Dingyuan Hu, et al.
BMC Cancer|November 14, 2018
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinomaDingyuan Hu, Daniel Ansari, Qimin Zhou, et al.
International Journal of Colorectal Disease|September 7, 2024
Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021Daopo Lin, Yang Jin, Xiaoxiao Shao, et al.
Zhonghua Nei Ke Za Zhi|September 30, 2014
[Associations of the decoy receptor and osteoprotegerin gene polymorphisms with ulcerative colitis in Chinese patients]Xiangyun Zheng, Ping Jiang, Hao Wu, et al.
Journal of Translational Medicine|September 5, 2020
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic markerJohannes Byrling, Theresa Kristl, Dingyuan Hu, et al.
Frontiers in Pharmacology|July 6, 2023
Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trialsDingyuan Hu, Liming Chen, Diqin Yan, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 12, 2019
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosisQimin Zhou, Roland Andersson, Dingyuan Hu, et al.
Pageof 4